Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 10.08.2021.

Biotechnology
GlaxoSmithKline
Therapy
Pharmacology
TAP Pharmaceuticals
Classification of Pharmaco-Therapeutic Referrals

Healthcare

@ldtimmerman shared
On Aug 5, 2021
Tachi Yamada, physician-scientist-executive, dies at 76. https://t.co/rLjQ9RERS5
Open
Tachi Yamada, Physician-Scientist-Biopharma Industry Leader, Dies at 76

Tachi Yamada, Physician-Scientist-Biopharma Industry Leader, Dies at 76

Tadataka “Tachi” Yamada, a distinguished physician-scientist who became a biopharmaceutical industry leader and a deeply respected advisor to biotech entrepreneurs, died the morning of Aug. ...

@celltherapy shared
On Aug 6, 2021
@khoslaventures @SVLATAMCap @SandHillAngels + @ycombinator invest $5.9M in @Encellin_Inc developing an encapsulation device to hold transplanted cells helping them survive in the body and release therapeutic molecules. https://t.co/6C4NIfPGBb Note: sounds like @SernovaCorp
Open
Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures and SV Latam Capital

Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures and SV Latam Capital

Encellin Closes $5.9M Seed Financing co-led by Khosla Ventures and SV Latam Capital

@BIODeutschland shared
On Aug 5, 2021
InflaRx Reports Second Quarter 2021 Financial & Operating Results https://t.co/U9QkWI1BIa
Open
08-2021-InflaRx Reports Second Quarter 2021 Financial & Operating Results

08-2021-InflaRx Reports Second Quarter 2021 Financial & Operating Results

Forward-looking statements appear in a number of places throughout this release and may include statements regarding our intentions, beliefs, projections, outlook, analyses and …

@matthewherper shared
On Aug 6, 2021
@Dereklowe @BioPharmGuy @dramyabernethy And, from MN on the conference call: https://t.co/liMIno4ssC https://t.co/aYlZkHhgWH
Open
ea145157ex99-3_cmlifescien3.htm

ea145157ex99-3_cmlifescien3.htm

EQRx has an incredibly innovative business model where they’re matching and taking advantage of all the breakthroughs in drug development and drug engineering and applying it to a …

@matthewherper shared
On Aug 6, 2021
My story laying out EQRX plan in January 2020. https://t.co/jBShOvUaru
Open
A ‘radical proposition’: A health care veteran tries to upend the system and bring drug prices down

A ‘radical proposition’: A health care veteran tries to upend the system and bring drug prices down

EQRx, a new company form Alexis Borisy, is announcing that is has raised $200 million from a bevy of top tech and biotech investors to make it happen.

@SWLifeSciences shared
On Aug 3, 2021
Gene Editing May Terminate Virus Transmission, Combat Heart & Brain Disease With a Single Shot: https://t.co/d5r9MgoT6m McAlinden Research explores the acceleration of gene-editing tech, noting the market is poised to expand. #biotech #CRISPR #geneediting $ARKG $NTLA $CRSP https://t.co/MobSgAzbCU
Open
Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot Contributed Research

Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot Contributed Research

McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for ...

@NatureBiotech shared
On Aug 3, 2021
@EmWaltz @justegg @GoodFoodInst @joshtetrick @goodmeat @MatrixMeats @CellsREvolved @AlephFarms @upsidefoods @mosa_meat @_SuperMeat_ Is lab meat about to hit your dinner plate? #NBTintheNews via @MotherJones https://t.co/ezmejrUtcl
Open
Is Lab Meat About to Hit Your Dinner Plate?

Is Lab Meat About to Hit Your Dinner Plate?

Splashy headlines suggest it might be. But experts say it's still a “moonshot” away.